Long-term toxicity of early stages of Hodgkin's disease therapy: The EORTC experience
- 1 February 1991
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 2 (uppl_2) , 77-82
- https://doi.org/10.1093/annonc/2.suppl_2.77
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Results of a prospective study evaluating the effects of mantle irradiation on pulmonary functionInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987Blood, 1989
- Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: Emphasis on the role of exploratory laparotomy and fractionationRadiotherapy and Oncology, 1988
- Late Toxicity of Radiotherapy in Hodgkin's Disease—The Role of Fraction SizeActa Oncologica, 1988
- Major complications and causes of death in patients treated for Hodgkin's disease.Journal of Clinical Oncology, 1987
- Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's diseaseCancer, 1987
- Radiation injurie of the gastrointestinal tract in Hodgkin's disease: The role of exploratory laparotomy and fractionationRadiotherapy and Oncology, 1984
- Coronary heart disease mortality after irradiation for Hodgkin's diseaseCancer, 1982
- Pulmonary Function Following Mantle-Field Irradiation for Hodgkin's DiseaseRadiology, 1974
- Lung function after mantle field irradiation in Hodgkin's diseaseCancer, 1973